These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24631484)

  • 1. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis.
    Fujáková M; Páleníček T; Brunovský M; Gorman I; Tylš F; Kubešová A; Řípová D; Krajča V; Horáček J
    Pharmacol Biochem Behav; 2014 Jul; 122():212-21. PubMed ID: 24631484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.
    Imre G; Salomons A; Jongsma M; Fokkema DS; Den Boer JA; Ter Horst GJ
    Pharmacol Biochem Behav; 2006 Jul; 84(3):392-9. PubMed ID: 16857251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats.
    Hiyoshi T; Hikichi H; Karasawa J; Chaki S
    Neurosci Lett; 2014 May; 567():30-4. PubMed ID: 24680852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of LY379268, a selective group II metabotropic glutamate receptor agonist on EEG activity, cortical perfusion, tissue damage, and cortical glutamate, glucose, and lactate levels in brain-injured rats.
    Stover JF; Sakowitz OW; Beyer TF; Dohse NK; Kroppenstedt SN; Thomale UW; Schaser KD; Unterberg AW
    J Neurotrauma; 2003 Apr; 20(4):315-26. PubMed ID: 12866811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.
    Jones NC; Reddy M; Anderson P; Salzberg MR; O'Brien TJ; Pinault D
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):657-68. PubMed ID: 21733235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aberrant gamma frequency oscillations on prepulse inhibition.
    Jones NC; Anderson P; Rind G; Sullivan C; van den Buuse M; O'Brien TJ
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1671-81. PubMed ID: 24832766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation.
    Wischhof L; Aho HE; Koch M
    Pharmacol Biochem Behav; 2012 Jul; 102(1):6-12. PubMed ID: 22469865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
    Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.
    Imre G
    CNS Drug Rev; 2007; 13(4):444-64. PubMed ID: 18078428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis.
    Carter K; Dickerson J; Schoepp DD; Reilly M; Herring N; Williams J; Sallee FR; Sharp JW; Sharp FR
    Neuropharmacology; 2004 Dec; 47(8):1135-45. PubMed ID: 15567423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
    Fell MJ; Svensson KA; Johnson BG; Schoepp DD
    J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat.
    Feinberg I; Campbell IG; Schoepp DD; Anderson K
    Pharmacol Biochem Behav; 2002 Sep; 73(2):467-74. PubMed ID: 12117602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
    Fell MJ; Katner JS; Johnson BG; Khilevich A; Schkeryantz JM; Perry KW; Svensson KA
    Neuropharmacology; 2010 Mar; 58(3):632-9. PubMed ID: 19951716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.